Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis.
Br J Pharmacol
; 178(6): 1373-1387, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33486755
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cannabinoids
/
Amyotrophic Lateral Sclerosis
Limits:
Humans
Language:
En
Journal:
Br J Pharmacol
Year:
2021
Document type:
Article
Affiliation country:
España